Lessons from COVID vaccine development and approval can aid the process.
According to Uğur Şahin and Özlem Türeci, the founders of the German company BioNTech, mRNA vaccines that can help target cancer could be ready for use before the end of this decade, The Guardian.
Wildpixel/iStock.
BioNTech’s big pivot.
Comments are closed.